This peptide has the potential to enhance muscle endurance by promoting protein synthesis and inhibiting protein breakdown
Among 1 IHA outcome estimate, 1 showed a significant reduction
Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, Laven JSE, Roeters van Lennep JE, Roseboom TJ, Hoek A (2020) Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
There are currently no randomised controlled trials evaluating GLP-1 receptor agonists as a treatment for rheumatoid arthritis, and these medications are not licensed or recommended for this indication by the MHRA, NICE, or the European Medicines Agency (EMA)
Of those, 30 patients were diagnosed with NAION (incidence rate: 4.83)